VESIcare For Improving OAB Symptoms in Patients Undergoing IGRT of the Prostate

NCT01777217 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated

Conditions

Over-Active Bladder

Interventions

DRUG: Solifenacin succinate
DRUG: Placebo

Sponsor

Advanced Research Network

Collaborators

[object Object]